SYNB-8802

N/A

Report date: 2024/01/08 17:38:13

Base Information

Drug NameSYNB-8802
Drug Alias NameSYNB-8802SYNB8802v1SYNB-8802-v-1
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulatorsOxalates inhibitors
TargetsOxalates
Therapy Area/IndicationsHyperoxaluria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynlogic IncGinkgo Bioworks Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynlogic Inc
Inactive CompaniesN/A
Active IndicationsHyperoxaluria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A